Semax vs Selank: Neuropeptide Research Comparison

Semax and Selank are both synthetic heptapeptides developed at Russian scientific institutions, both approved as prescription medications in Russia, and both studied for cognitive and neuroprotective effects. Despite these similarities, they are derived from completely different parent molecules and work through distinct mechanisms.

Origins and Mechanism Differences

Semax (Met-Glu-His-Phe-Pro-Gly-Pro) is a synthetic analog of ACTH(4-7) — a fragment of adrenocorticotropic hormone. It was developed at the Institute of Molecular Genetics, Russian Academy of Sciences. Semax’s primary mechanism involves upregulation of BDNF (brain-derived neurotrophic factor) and modulation of the BDNF/TrkB signaling pathway, which is critical for neuronal survival, differentiation, and synaptic plasticity (PMID: 16996037).

Selank (Thr-Lys-Pro-Arg-Pro-Gly-Pro) is based on tuftsin, a naturally occurring immunomodulatory tetrapeptide derived from IgG. It was developed at the same institute. Selank modulates GABAergic and serotonergic neurotransmission, increases enkephalin expression, and also affects BDNF — but primarily through anxiety and stress-response pathways (PMID: 18577768).

The simplest distinction: Semax is primarily studied as a nootropic (cognitive enhancer) and neuroprotectant, while Selank is primarily studied as an anxiolytic (anxiety-reducing) with secondary nootropic properties.

Key Research Highlights

Cognitive Enhancement: Semax shows stronger effects on learning and memory consolidation in animal models, likely through its more direct BDNF/TrkB activation. Selank’s cognitive effects appear secondary to its anxiolytic action — reduced anxiety improves cognitive performance (PMID: 16996037).

Anxiety Reduction: Selank demonstrates more potent anxiolytic effects, comparable to benzodiazepines but without sedation, dependence, or cognitive impairment (PMID: 25747365).

Neuroprotection: Both peptides show neuroprotective properties in ischemic and oxidative stress models, but through different pathways — Semax via neurotrophic support, Selank via anti-inflammatory and anti-apoptotic mechanisms.

Immune Effects: Selank retains immunomodulatory properties from its tuftsin parent. Semax has minimal direct immune effects.

Quick Reference

Property	Semax	Selank
Parent Molecule	ACTH(4-7)	Tuftsin
Amino Acids	7	7
Primary Effect	Nootropic / neuroprotection	Anxiolytic / nootropic
Key Pathway	BDNF/TrkB	GABA/serotonin, enkephalin
Immune Effects	Minimal	Immunomodulatory (tuftsin-based)
Regulatory Status	Approved in Russia	Approved in Russia (2009)
Best For (Research)	Cognition, neuroprotection	Anxiety, stress-related cognition

Further Reading

For comprehensive analyses, see our Semax Research Guide | Selank Research Guide

Also relevant: All Nootropic Peptides Compared →

Written by NorthPeptide Research Team